Open original FDA record ↗Recall record
- FDA identifier
- Z-0317-06
- Company in FDA record
- Dakocytomation California Inc
- FDA classification date
- Dec 23, 2005
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
This recall has been initiated due to a formulation error in the EnVision+ visualization reagent.
Source facts
- Action
- Notification letter dated October 14, 2005 was sent by certified mail to cosignees instructing dosposal of product.
- Initiated
- 2005-10-14
- Root cause
- Other
- Terminated
- 2007-01-29
- Distribution
- Nationwide to: AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, MI, MO, MN, NC, NE, NJ, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, VA, VT, WA, WI, and WV. Worldwide to: Argentina, Bermuda, Brazil, Canada, Costa Rica, Denmark, Japan, Mexico, New Zealand, and Uruguay.
- Recall number
- Z-0317-06
- Recall status
- Terminated
- CDRH record ID
- 42810
- FDA classified
- 2005-12-23
- Recall event number
- 33957